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ABSTRACT
Background and the purpose of the study: Gnidilatimonoein (Gn), a new diterpene ester from 
Daphne mucronata, possesses strong anti-metastasis and anti-tumor activities. In this study, 
its apoptosis and differentiation capabilities were evaluated by using the leukemia HL-60 cell 
line. 
Material and methods: Cell prolifaration inhibition was estimated by MTT assay. The occurrence 
of apoptosis was evaluated by EtBr/AO double staining technique, cell cycle analyses and 
detection of apoptotic cells by Annexin V-FITC and propodium iodide (PI). Differentiation of 
the cells was determined by NBT reduction assay and the expression of specific cell surface 
markers such as CD14 and CD11b, were analyzed by flow cytometry.  
Results: The drug decreased the growth of the cells dose- and time-dependently and the IC50 
was found to be 1.3 µM. Our data suggested that Gn induced both monocytic differentiation and 
apoptosis among HL-60 cells. In addition, cell cycle analyses showed an increase in G1 phase 
population by 24 hrs, which was gradually replaced by Sub-G1 cell population (apoptotic cells) 
by 72 hrs. 
Conclusion: Based on these data, the Gn-treated HL-60 cells displayed differentiation-dependent 
apoptosis. Thus, Gn might be a good candidate for differentiation therapy of leukemia, pending 
full biological evaluation of the compound among the wide array of leukemia cells.
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INTRODUCTION
A characteristic abnormality of some types of 
leukemia such as ALL, AML and APL is that they 
are blocked at an early stage of their developments 
and fail to differentiate into functional mature cells 
(1). Recently, several scientific achievements have 
emphasized on using differentiation therapy as an 
elegant alternative to chemotherapy with potent 
cytotoxic agents. This approach could theoretically 
limit the patient exposure to unwanted side effects 
of cytotoxic drugs and, more importantly, it would 
modulate the remission and the cure rates (2). 
Human promyelocytic leukemia cells, derived 
from a patient with acute promyelocytic leukemia 
(APL), following treatment with respective inducers 
could be differentiated either along granulocytic 
or along monocytic lineage, and thus this cell 
line provide a good in vitro model for research 
and differentiation studies (3). HL-60 cells are 
induced to differentiate into mature functional 
neutrophils by dimethylsulfoxide (DMSO), retinoic 
acid (RA), anthracyclines, 6-thioguanine (6-
TG), 5-azacytidine and tunicamycin (4-6) or into 
macrophage/monocyte-like cells by phorbol ester 
(12-O-tetradecanoylphorbol 13-acetate [TPA]), 
1,25-dihydroxyvitamin D3 and cytosine arabinoside 
(Ara-C) (7). However, their clinical applications 
have always been associated with significant side 
effects  (8).  Therefore,  in  recent  years  significant 
efforts have been devoted to identify natural agents 
having differentiation capability and being devoid 
of general toxicities. In that respect, plants have 
been the center of attention for obtaining novel anti-
leukemia  agents  (9).  Many  flavonoids,  phenolic 
compounds and daphnane-type diterpene esters such 
as genkwadaphnin, yuanhuacine, genididin, catechin, 
epicatechin, taxifolin and pycnogenol (10,11) 
have so far been evaluated and shown to induce 
differentiation and/or apoptosis among different   
leukemia cell lines. It has been also reported that the 
anti-leukemia property of these compounds is mainly 
due to their effects on different enzyme activities 
such as Inosin 5΄-Monophosphate Dehydrogenase 
(IMPDH), thymidine kinase and DNA polymerase. 
IMPDH catalyses the rate limiting reaction of 
de novo guanine nucleotide biosynthesis and its 
activity has been associated with the regulation of 
cellular growth, differentiation and apoptosis (12). 
Results of previous studies have classified Gn as a 
strong anti-proliferative agent among several human 
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cancer cell lines (13). It has been also found that Gn 
is capable of inhibiting IMPDH activity, which is 
usually up regulated in human leukemia cell lines 
(14). Studies of different independent groups have 
indicated that several inducers promote programmed 
cell death (apoptosis) in addition of causing terminal 
differentiation. In that line, it has been shown that 
the proportion of terminally differentiated cells was 
much higher than that of apoptotic cells (recorded 
in the same culture plate). This might suggest that 
a fraction of differentiated cells undergo apoptosis 
(15). 
To further confirm the differentiation and apoptosis 
induction activities of Gn in leukemia cell lines, 
it was decided to do complementary studies in 
human promyeloid leukemia HL-60 cells having the 
following unique criteria: susceptibility to a variety 
of agents to induce differentiation by as much as 90%, 
the capacity to differentiate either to granulocyte-like 
or  to  monocyte/macrophage-like  cells  and  finally 
bring a model of AML type 2 representing both 
differentiation and apoptosis activities (16). It was 
also aimed to determine whether anti-proliferative 
and cytotoxic effects of Gn in HL-60 cells can affect 
the apoptosis phenomenon and to evaluate possible 
differentiation effect(s) of this compound in human 
promyeloid leukemia HL-60 cells. 
MATERIAL AND METHODS 
Materials
The cell culture medium (RPMI-1640), fetal bovine 
serum (FBS) and penicillin–streptomycin were 
purchased from Gibco BRL (Life technology, 
Paisley, Scotland). Cell line was obtained from 
Pasteur Institute of Iran (Tehran, Iran). 12-O-
tetradecanoyl porbol-13-acetate (TPA), propidium 
iodide (PI), RNase (DNase free), nitro blue 
tetrazolium (NBT) and sodium azide were purchased 
from Sigma Chem. Co. (Germany). Ethidium 
bromide (EtBr) and acridine orange (AO) were 
obtained from Pharmacia LKB Biotechnology AB 
Uppsala (Sweden). Annexin-V and anti CD14 and 
CD11b antibodies were purchased from IQ Products 
(Groningen, Netherlands).
Plant extraction and purification of Gn
Extraction and purification of Gn has been described 
in detail previously (17). The purity of the compound 
by 99% was confirmed by HPLC technique.
Cell culture
HL-60 cells (4×104 cells/ml) were grown in RPMI 
1640 medium supplemented with 20% (V/V) FBS, 
100 μg/ml streptomycin and penicillin (100 U/ml). 
The cultured cells were incubated under 5% CO2 
humidified  atmosphere  at  37°C.  For  the  various 
experiments, the cells were seeded at a density of 
4×104 cells/ml in the presence or absence of Gn. 
Cell proliferation assay 
Cell proliferation was estimated by MTT assay (18). 
Briefly,  HL-60  cells  were  seeded  at  a  density  of 
4×104 cells/ml in 96 well plates. After being treated 
with various concentrations of Gn for different time 
intervals, 10 μl of MTT (5 mg/ml) was added to 
each well. The plates were incubated at 37°C for 4 
hrs. Then the solution was removed and 100 μl of 
DMSO was added to each well. After rocking for 
30 min, absorbance values were determined at 570 
nm using a microplate reader (ELx 800 Microplate 
Reader, Bio-TEK).
Nitroblue tetrazolium (NBT) reduction assay
In order to evaluate the differentiation of HL-60 
cells toward macrophage/monocyte lineage, NBT 
assay was performed as described by Sakashita et al. 
(19) with a slight modification. In brief, cells were 
harvested by centrifugation and re suspended in 200 
μl RPMI 1640 containing NBT solution (4 mg/ml) 
and 2 μg/ml TPA, and the cell suspensions were then 
incubated at 37°C for 30 min. The differentiated 
cells were identified by their intracellular reduced 
dark blue formazan deposits. 
Analyses of apoptotic cells by Annexin V-FITC and 
propodium iodide (PI)
The cells were treated with the drug for 72 and 96 
hrs. After harvesting, the cells were washed twice 
with  PBS  and  re-suspended  in  100  μl  binding 
buffer (10 mM HEPES/NaOH, of pH 7.4, 140 mM 
NaCl and 2.5 mM CaCl2). FITC-Annexin V (10 μl) 
was added to the cells followed by the addition of 
10 μl of PI(50 μg/ml of PBS). The samples were 
incubated for 10 min in the dark at 4°C and then 
analyzed by flow cytometry.
Flow  cytometric  analyses  of  the  cell  surface 
expression antigens 
Control and Gn-treated cells were collected and 
washed twice with ice-cold PBS. The cells were 
re-suspended in PBS containing 1% FBS and 
0.1% sodium azide. Then 10 μl of PE-conjugated 
monoclonal antibody against CD14 and FITC-
conjugated monoclonal antibody against CD11b 
were added to 100 μl of the cell suspension and 
incubated at 4°C for 30 min. For each population, 
a matched isotype control monoclonal antibody 
(mAb)  was  used  to  define  the  fluorescence 
background. Finally, after washing, at least 104 cells 
were analyzed by flow cytometry (Partec PAS) for 
the intended antigens.
Cell cycle analyses by flow cytometry  
The distribution of cells among different phases 
of their growth cycles was achieved by using a 
published  method  with  slight  modification  (20). 
Briefly,  after  washing  the  cells  for  twice  with 
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containing 10 mM Tris/HCl, 0.1% Triton X-100, 
200 µg/ml RNase and 50 µg/ml propidium iodide, 
they were incubated at room temperature for 30 min. 
The stained cells were analyzed by flow cytometry. 
Analyses  of  apoptotic  cells  by  EtBr/AO  double 
staining
Nuclear morphology of the cells was studied 
by  fluorescence  microscopy  after  staining  with 
ethidium bromide/acridine orange (EtBr/AO). The 
cells (4×104 cells/ml) cultured in the presence or 
absence of the drug were collected and washed in 
cold PBS. Then the EtBr/AO solution (1:1 v/v) was 
added to the cell suspension at a final concentration 
of 100 µg/ml and then they were incubated at room 
temperature for 5 min. The stained cells were 
evaluated  under  a  fluorescent  microscope  (Zeiss, 
Axioskope 2 plus, Germany). 
Caspase-3 activity assay   
Caspase-3 activity was evaluated according to 
the manufacturer’s instruction of the relevant kit 
(Biosourse, Nirelles, Belgium). Control and the Gn-
treated cells were harvested and lysed in 50 μl of 
the cell lysis buffer. Fifty microliters of the reaction 
buffer (containing 10 mM DTT) and 5 µl of the 
relevant conjugated substrate (DEVD-pNA) at a 
concentration of 4 mM were added to each lysate. 
The mixture was incubated at 37°C for 2 hrs and the 
absorbance was then measured at 405 nm.
Statistical analyses 
Data are expressed as mean±SD. All experiments 
were performed in triplicates except for Caspase-3 
activity assay which was performed in duplicates. 
For statistical analyses, the student’s t-test was 
applied. P values of less than 0.05 were considered 
significant.
RESULTS
Gn inhibits proliferation of HL-60 cells
As it is shown in figure 1, the drug inhibited the 
proliferation of HL-60 cells in a time- and dose-
dependent manner. After 72 hrs of treatment, the cell 
proliferation was reduced by 50% at 1.3 µM of the 
drug. Treatment of HL-60 cells with 0.5-3 µM of Gn 
for 3 days resulted in cell death by 24-72%. 
NBT assay
As shown in figure 2, HL-60 cells were differentiated 
by the drug in a time- and dose-dependent manner. 
Incubation of the cells with 0.5-3 µM of Gn for 48 to 
72 hrs increased the cell differentiation by 17-56% 
and 24-66%, respectively. 
Effect  of  Gn  on  the  expression  of  cell  surface 
antigens
As it is evident in figure 3, treatment of the cells 
with a single dose (1.3 µM) of Gn resulted in 
gradual increase in the cell surface expressions of 
both antigens, CD14 and CD11b. Flow cytometric 
diagrams clearly indicated the enhanced expression 
of CD11b (by 13, 32 and 39%) and CD14 (by 14, 16 
and 20%) after 24, 48 and 72 hrs, respectively.
Gn induced G1 cell cycle arrest
After treatment of HL-60 cells with 1.3 µM of the 
drug for 24 hrs, the cell population in G1 phase 
increased steadily from 43 to 61% which was 
accompanied with a slight decrease in S (11%) and 
G2 (7%) phases. However, longer exposures to the 
drug led to the appearance of Sub-G1 cell population 
which increased to 59% after 72 hrs (Fig 4). These 
results clearly indicated that Gn induced post G1-
arrest apoptosis among the drug-treated cells.
Induction of apoptosis by Gn in HL-60 cells 
To verify the apoptotic nature of the cell death 
caused by Gn, we evaluated the nuclear changes 
by EtBr/AO double staining technique. Cultures 
exposed to the drug (1.3 µM) contained apoptotic 
cells with condensed and fragmented nuclei after 
48 hrs (Fig 5A). In this figure, the nuclear region 
of viable cells is uniformly green and that of 
the apoptotic cells are orange with bright dots 
corresponding to nuclear chromatin fragmentation. 
Exposure of HL-60 cells to different concentrations 
of the drug induced apoptosis in a dose-dependent 
manner (Fig 5B). To further confirm the occurrence 
of apoptosis, the drug-treated cells were subjected 
to Annexin V/PI double staining followed by flow 
cytometry analyses. Exposure of the cells to 1.3 
µM concentration of Gn induced time-dependent 
apoptosis among the cells (Fig 5C). 
Activation of pro-caspase-3 by Gn
Apoptosis is often associated with caspase(s) 
activation. Among the caspase family, caspase-3 
is responsible for proteolytic cleavage of a number 
of substrates and is the main key executioner of 
apoptosis. In this study, the drug-treated apoptotic 
cells showed, as indicated in figure 6, a significant 
increase in the activity of caspase-3 (1.5-3 folds) after 
72 hrs of exposure to different concentrations (0.5-
2 µM) of Gn, indicating that Gn-induced apoptosis 
among the treated cells is caspase-3 dependent.
DISCUSSION 
The paradigm that some types of leukemias are 
characterized  by  the  modification  of  2  sets  of 
genes, those that give the proliferative criterion 
and the second one that is associated with a block 
of differentiation, is still as valid today as it was 
3 decades ago. To date, the hope that a variety of 
common chemicals would be identified for leukemia 
cells differentiation, similar to the successes of ATRA 
(All Trans Retinoic Acid) in APL, has not come to Proliferation inhibition, cell cycle arrest and apoptosis induced in HL-60 cells 148
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Figure 2. Changes in the extent of HL-60 cell differentiation induced by Gn at various 
concentrations. Differentiation was assayed by the NBT test. HL-60 cells were incubated 
with Gn (0.5-3 µM) for 48 and 72 hrs and NBT-positive cells were counted. Values are 
means ± SD of triplicate measurements (P< 0.05). 
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Figure 2. Changes in the extent of HL-60 cell differentiation induced by Gn at various concentrations. Differentiation was assayed 
by the NBT test. HL-60 cells were incubated with Gn (0.5-3 µM) for 48 and 72 hrs and NBT-positive cells were counted. Values are                             
means±SD of triplicate measurements (P< 0.05).
reality on a broad scale (21). This might be attributed 
to the fact that the candidate substances have been 
unable to target a disease-specific lesion, have short 
lives and have been accompanied by a variety of side 
effects such as drug-resistance and cytotoxicity (21). 
Based on these facts, a larg number of investigations 
are  going  on  to  find  novel  anti-leukemia  agents 
from natural sources mainly from plant kingdom. 
Regarding the established mode of action of 3-HK 
and structural similarities between 3-HK and Gn, 
it was of interest to evaluate the differentiation and 
apoptosis activities of Gn relative to 3-HK. In the 
present investigation, it became evident that Gn 
induced G0/G1 cell cycle arrest, differentiation 
and apoptosis in HL-60 cells. To determine the 
anti-leukemia effect of Gn, the MTT assay was 
used. After treatment with Gn, the proliferation 
rate of HL-60 cells declined (Fig 1). Regarding 
 
 
17 
 
Figure  1.€€p danEffect of Gn on HL-60 cell proliferation. Cells were exposed to the 
indicated amounts of Gn (0.5-3 µM) for 24, 48 and 72 hrs. The cell growth inhibition was 
measured by MTT assay. Cell proliferation inhibition in each treatment is expressed as 
percentage of the treated cell number relative to the untreated control cells. Results are 
means ± SD of three measurements (P< 0.05). 
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Figure 1. Effect of Gn on HL-60 cell proliferation. Cells were exposed to the indicated amounts of Gn (0.5-3 µM) for 24, 48 and 72 hrs. 
The cell growth inhibition was measured by MTT assay. Cell proliferation inhibition in each treatment is expressed as percentage of the 
treated cell number relative to the untreated control cells. Results are means±SD of three measurements (P< 0.05).
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Figure 3. Effects of Gn on the expression of differentiation markers in HL-60 cells. HL-60 cells were treated with 1.3 μM of Gn for 
different time intervals. Differentiation was assessed by evaluating the extent of CD11b and CD14 expression using flow cytometry 
technique.
differentiation, HL-60 cells have a dual potential to 
differentiate to monocytes or to granulocytes (19). 
Results of this study indicated that Gn significantly 
induced HL-60 cells to differentiate along the 
monocytic lineage, as indicated by morphological 
examination (data not shown), NBT reduction 
assay (Fig 2) and most importantly, the expression 
of both cell surface markers CD11b and CD14 (Fig 
Control
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Figure 4. Cell cycle distribution of the cells upon Gn treatment. The cells were treated with 1.3 μM of the drug for 24 hrs and 72 hrs and 
after staining with propidium iodide (PI), analyzed by flow cytometry.   
3). These observations were almost similar to our 
previous data on the effect of 3-HK on HL-60 cells 
(22), through the cytotoxic potency of Gn was found 
to be weaker (IC50 = 1.3 µM) compared to the IC50 of 
3-HK which is around 10 nM. 
The differentiation of the Gn-treated cells was 
associated with significant arrest of the cells in G1 
phase of their growth progression cycle, which is 
in accordance to the present literatures data (23). 
However, after 24 hrs, the cell population at G1 
phase decreased and the sub-G1 peak (representing 
apoptosis) appeared after 72 hrs (Fig 4) confirming 
the death of the Gn-treated cells by apoptosis. 
Morphological changes and also the appearance of 
Sub-G1 peak in Gn-treated cells clearly confirmed 
the occurrence of apoptosis among Gn- treated cells. 
To further verify the occurrence of apoptosis, the 
nuclear morphological changes following AO/EtBr 
staining and FITC-annexin V/PI treatment assay 
were investigated. Results confirmed apoptotic cell 
death among Gn-treated cells (Fig 5). In addition, 
results supported that apoptosis was caspase-
3 dependent (Fig 6). This is in contrast to some 
present data in literature concerning the caspase-
3-independent apoptotic effects of some anticancer 
drugs (24). 
 In conclusion, results of this investigation clearly 
showed that Gn is a natural anti-proliferative and 
differentiation-inducing agent which induced 
macrophage/monocyte differentiation-dependent 
apoptosis in human promyeloid leukemia HL-60 
cells. Therefore, this new agent might be valubale 
candidate for pharmaceutical purposes. 
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Figure 5. Effects of Gn on apoptosis induction among HL-60 cells. (A) Gn-treated HL-60 cells (1.3 µM, 48 hrs) were stained with 
EtBr/ AO and then observed by a  fluorescent microscope. Gn significantly induced chromatin condensation and nuclei fragmentation. 
Magnification 40x. (B) Cells were treated with different concentrations of Gn for 72 hrs. The percentage of apoptotic cells increased 
dose dependently. (C) HL-60 cells were treated with 1.3 µM of Gn for 72 and 96 hrs followed by FITC–Annexin V/PI flow cytometry 
analyses.
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Figure 5. Effects of Gn on apoptosis induction among HL-60 cells. (A) Gn-treated HL-60 cells (1.3 µM, 48 hrs) were stained with 
EtBr/ AO and then observed by a  fluorescent microscope. Gn significantly induced chromatin condensation and nuclei fragmentation. 
Magnification 40x. (B) Cells were treated with different concentrations of Gn for 72 hrs. The percentage of apoptotic cells increased 
dose dependently. (C) HL-60 cells were treated with 1.3 µM of Gn for 72 and 96 hrs followed by FITC–Annexin V/PI flow cytometry 
analyses.
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Figure 6. Effect of Gn on caspase-3 activation in HL-60 cells. HL-60 cells were treated 
with various concentrations of Gn (0.5-2 μM) for 72 hrs. After incubation time, the activity 
of caspase-3 enzyme was determined by DEVD-pNA. Results are means ± SD of two 
independent measurements (P< 0.05). 
  
Concentration (µM)
 
 
22 
 
 
Figure 6. Effect of Gn on caspase-3 activation in HL-60 cells. HL-60 cells were treated 
with various concentrations of Gn (0.5-2 μM) for 72 hrs. After incubation time, the activity 
of caspase-3 enzyme was determined by DEVD-pNA. Results are means ± SD of two 
independent measurements (P< 0.05). 
  
Figure 6. Effect of Gn on caspase-3 activation in HL-60 cells. HL-60 cells were treated with various concentrations of Gn (0.5-2 μM) 
for 72 hrs. After incubation time, the activity of caspase-3 enzyme was determined by DEVD-pNA. Results are means±SD of two 
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